Clinical Trials on Non-small Cell Lung Cancer Stage III in Belgium
Total 438 results
-
University Hospital, EssenRecruitingNSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIABelgium, Germany, Netherlands
-
Leiden University Medical CenterJessa Hospital; The Netherlands Cancer InstituteRecruitingImmunotherapy | Non Small Cell Lung Cancer Stage IIINetherlands, Belgium
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, HellasCompletedNon-small Cell Lung Cancer Stage IIISwitzerland, Netherlands, Spain, Belgium, Germany
-
University Hospital, GhentNationaal KankerplanTerminatedInoperable Early Stage Non-small Cell Lung CancerBelgium
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
University Hospital, GhentNationaal KankerplanTerminatedEarly Stage Non-small Cell Lung CancerBelgium
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
Centre Hospitalier Universitaire de LiegeActive, not recruitingNon-small Cell Lung CancerBelgium
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
MSD Belgium BVBACompletedStage IV Non-small Cell Lung CancerBelgium
-
Hasselt UniversityJessa Hospital; University Hospital, Ghent; University GhentRecruitingNon-small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
University Hospital, GhentUniversity Ghent; Kom Op Tegen KankerActive, not recruitingNon-small Cell Lung CancerBelgium
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IVUnited States, Canada, France, Italy, Spain, United Kingdom, Belgium, Poland, Brazil, Germany, Hungary, Peru, Russian Federation, Turkey, Australia, Chile, Austria, Netherlands, Portugal, Israel, Mexico, Romania, Sweden, Ukraine, Bulgaria, Argenti...
-
University Hospital, GhentUniversity Ghent; Kom Op Tegen KankerActive, not recruitingNon-small Cell Lung Cancer MetastaticBelgium
-
Universitair Ziekenhuis BrusselRecruitingNon-small Cell Lung CancerBelgium
-
University Hospital, GhentHasselt University; Jessa Hospital; AZ Sint-Jan AV; AZ Delta; Ziekenhuis Oost-LimburgRecruitingNon Small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
Jules Bordet InstituteRecruitingNon Small Cell Lung CancerBelgium
-
Universitair Ziekenhuis BrusselRecruitingNon Small Cell Lung CancerBelgium
-
University Hospital, AntwerpSanofi; Universiteit AntwerpenCompletedNon-small Cell Lung CancerBelgium
-
Universitaire Ziekenhuizen KU LeuvenRecruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorBelgium
-
University Hospital, AntwerpEli Lilly and Company; Universiteit AntwerpenCompletedNon-Small-Cell-Lung CancerBelgium
-
ETOP IBCSG Partners FoundationEuropean Organisation for Research and Treatment of Cancer - EORTC; AmgenTerminatedLung Cancer Non-small Cell Stage IVIreland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland
-
Vrije Universiteit BrusselKom Op Tegen KankerUnknownLung Cancer, Non-small CellBelgium
-
ETOP IBCSG Partners FoundationHoffmann-La RocheTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentIreland, Spain, Belgium, Italy, Netherlands, Switzerland
-
Universitair Ziekenhuis BrusselRecruitingSolid Tumor | Non Small Cell Lung CancerBelgium
-
Centre Hospitalier Universitaire de LiegeRecruitingNon-small Cell Lung CancerBelgium
-
University Hospital, GasthuisbergCompletedLung Cancer | Non Small Cell Lung CancerBelgium
-
Maastricht Radiation OncologyUniversitaire Ziekenhuizen KU LeuvenCompletedNon Small Cell Lung CancerNetherlands, Belgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Eli Lilly and CompanyCompleted
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
University Hospital, AntwerpAstraZeneca; Universiteit AntwerpenCompletedNon Small Cell Lung CancerBelgium
-
Thoraxklinik-Heidelberg gGmbHCompletedNon Small Cell Lung CancerBelgium, Germany, Luxembourg
-
European Organisation for Research and Treatment...Terminated
-
Jules Bordet InstituteCompletedMetastatic Melanoma | Colorectal Cancer Metastatic | Metastatic Non-Small Cell Lung CarcinomaBelgium
-
GenmabTerminatedNon Small Cell Lung CancerBelgium, United States, France, Netherlands, United Kingdom
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
TransgeneBristol-Myers SquibbCompletedNon Small Cell Lung Cancer MetastaticHungary, France, United States, Belgium
-
Hoffmann-La RocheCompleted
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
University Hospital, AntwerpUniversiteit Antwerpen; Belgian Cancer RegistryEnrolling by invitationSmoking Cessation | Lung Cancer | Lung Cancer, Nonsmall Cell | Lung Cancer, Small CellBelgium
-
University Hospital, AntwerpEli Lilly and Company; Universiteit AntwerpenCompleted
-
AZ-VUBSanofiUnknownNon-Small-Cell Lung CarcinomaBelgium
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerUnited States, Belgium, United Kingdom
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium